Abiraterone acetate, Niraparib, and Prednisone
About
Membership operator: AND
Therapies: 3
Therapies
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (2) | BRCA1 oncogenic variants | Prostate Adenocarcinoma | Abiraterone acetate, Niraparib, Prednisone | |
| EMA (1) FDA (2) | BRCA1 pathogenic variants | Prostate Adenocarcinoma | Abiraterone acetate, Niraparib, Prednisone | |
| EMA (1) FDA (4) | BRCA2 oncogenic variants | Prostate Adenocarcinoma | Abiraterone acetate, Niraparib, Prednisone | |
| EMA (1) FDA (4) | BRCA2 pathogenic variants | Prostate Adenocarcinoma | Abiraterone acetate, Niraparib, Prednisone |